Ploidy as a prognostic feature in colonic adenocarcinoma

Archives of Surgery

Volumn 131, Issue 6, 1996, Pages 587-592

  Takanishi Jr , Danny M ^a   Hart, John ^a   Covarelli, Piero ^a   Chappell, Richard ^b   Michelassi, Fabrizio ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b University of Wisconsin Madison   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER STAGING; CELL CYCLE; COLON ADENOCARCINOMA; CONTROLLED STUDY; DIPLOIDY; DNA CONTENT; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; RACE; SURVIVAL RATE; TETRAPLOIDY; TREATMENT OUTCOME;

EID: 0029885288     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.1996.01430180013002     Document Type: Article

References (26)

1. Michelassi F, Block GE, Vannucci L, Montag A, Chappell R. A five- to twenty-one year follow-up and analysis of 250 patients with rectal adenocarcinoma. Ann Surg. 1988;208:379-389.
2. Michelassi F, Ayala JJ, Balestracci T, Chappell R, Goldberg R, Block GE. Verification of a new clinico-pathologic staging system for colonic adenocarcinoma. Ann Surg. 1991;213:11-18.
3. Lifson B, Pizzolo, JG, Elhosseiny JG, Choudhury MS, Melamed MR. Comparison of fluorescence in situ hybridization and flow cytometric DMA ploidy analysis in paraffin-embedded prostatic adenocarcinoma specimens. Analyt Quant Cytol Histol. 1995;17:93-99.
4. Balslev I, Christensen IB, Rasmussen BB, et al. Flow cytometric DNA ploidy defines patients with poor prognosis in node-negative breast cancer. Int J Cancer. 1994;56:16-25.
5. Midulla C, Giovagnoli, MR, Valli C, Vecchione A. Correlation between ploidy status, erb-b2, and p53 immunohistochemical expression in primary breast carcinoma. Anal Quant Cytol Histol. 1995;17:157-162.
6. D'Agnano I, D'Angelo C, Savarese A, et al. DNA ploidy, proliferate index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers. Lab Invest. 1995;72:432-438.
7. Yonemura Y, Fonseca L, Tsugawa K, et al. Prediction of lymph node metastasis and prognosis from the assay of the expression of proliferating cell nuclear antigen and DNA ploidy in gastric cancer. Oncology. 1994;51:251-257.
8. Friedlander ML, Hedley DW, Taylor IW. Clinical and biological significance of aneuploidy in human tumors. J Clin Pathol. 1984;37:961-974.
9. Williams NN, Daly JM. Flow cytometry and prognostic implications in patients with solid tumors. Surg Gynecol Obstet. 1990;171:257-266.
10. Emdin SO, Stenling R, Roos G. Prognostic value of DNA content in colorectal carcinoma: a flow cytometric study with some methodologic aspects. Cancer. 1987;60:1282-1287.
11. Baretton G, Gille J, Oevermann E, Lohrs U. Flow-cytometric analysis of the DNA-content in paraffin-embedded tissue from colorectal carcinomas and its prognostic significance. Virchows Arch B Cell Pathol. 1991;60:123-131.
12. Wolley RC, Schreiber K, Koss LG, Karas M, Sherman A. DNA distribution in human colon carcinomas and its relationship to clinical behavior. J Natl Cancer Inst. 1982:69:15-22.
13. Armitage NC, Robins RA, Evans DF, Turner DR, Baldwin RW, Hardcastle JD. The influence of tumour cell DNA abnormalities on survival in colorectal cancer. Br J Surg. 1985;72:828-830.
14. Kokal W, Sheibani K, Terz J, Harada JR. Tumor DNA content in the prognosis of colorectal carcinoma. JAMA. 1986;255:3123-3127.
15. Scott NA, Rainwater LM, Wieand HS, et al. The relative prognostic value of flow cytometric DNA analysis and conventional clinicopathologic criteria in patients with operable rectal carcinoma. Dis Colon Rectum. 1987;30:513-520.
16. Scott NA, Wieand HS, Moertel CG, Cha S, Beart RW, Lieber MM. Colorectal cancer: Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern. Arch Surg. 1987;122:1375-1379.
17. Harlow SP, Eriksen BL, Poggensee L, et al. Prognostic implications of proliferative activity and DNA aneuploidy in Astler-Coller Dukes' stage C colonic adenocarcinomas. Cancer Res. 1991;51:2403-2409.
18. Witzig TE, Loprinzi CL, Gonchoroff NJ, et al. DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinoma. Cancer. 1991;68:879-888.
19. Wiggers T, Arends JW, Schutte B, Volovics L, Bosman FT. A multivariate analysis of pathologic prognostic indicators in large bowel cancer. Cancer. 1988;61:386-395.
20. Frankfurt OS, Ardbuck SG, Greco WR, et al. Prognostic significance of DNA aneuploidy in human colorectal cancer. Proc Am Soc Clin Oncol. 1984;3:17.
21. Rognum TO, Thorud E, Lund E. Survival of large bowel carcinoma patients with different DNA ploidy. Br J Cancer. 1987;56:633-641.
22. Jones DJ, Moore M, Schofield PF. Prognostic significance of DNA ploidy in colorectal cancer: a prospective flow cytometric study. Br J Surg. 1988;75:28-33.
23. Melamed MR, Enker WE, Banner P, Janov AJ, Kessler G, Darzynkiewicz Z. Flow cytometry of colorectal carcinoma with three-year follow-up. Dis Colon Rectum. 1986;29:184-186.
24. Jones DJ, Moore M, Schofield PF. Refining the prognostic significance of DNA ploidy status in colorectal cancer: a prospective flow cytometric study. Int J Cancer. 1988;41:206-210.
25. Hastie TJ, Pregibon D. Generalized linear models. In: Chambers JM, Hastie TJ, eds. Statistical Models in S. Pacific Grove, Calif: Wadsworth and Brooks/Cole Advanced Books and Software; 1992:chap 6.
26. Hastie TJ. Generalized additive models. In: Chambers JM, Hastie TJ, eds. Statistical Models in S. Pacific Grove, Calif: Wadsworth and Brooks/Cole Advanced Books and Software; 1992:chap 7.